Form D · Pharmaceuticals
THAR PHARMACEUTICALS INC
Pittsburgh, PA · CIK 0001428369
Offering snapshot reported Apr 5, 2016 · SEC filing
- Reported sold
- $1.37M Offering amount: $3M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Aug 19, 2014 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$115,000 → $1,371,500
- Reported investors2 → 18
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 5, 2016 | Amendment | $1,371,500 | $1,256,500vs Sep 2, 2014 | 18 | SEC filing |
| Sep 2, 2014 | Initial | $115,000 | No comparison | 2 | SEC filing |
| Nov 12, 2013 | Amendment | $3,940,000 | $1,990,000vs Apr 19, 2013 | 32 | SEC filing |
| Apr 19, 2013 | Amendment | $1,950,000 | $1,545,000vs Nov 30, 2012 | 21 | SEC filing |
| Nov 30, 2012 | Initial | $405,000 | No comparison | 6 | SEC filing |
| Jul 3, 2012 | Amendment | $325,000 | $75,000vs Nov 18, 2011 | 3 | SEC filing |
| Nov 18, 2011 | Initial | $250,000 | No comparison | 1 | SEC filing |
| Jan 3, 2011 | Amendment | $4,311,656 | $2,286,656vs Dec 8, 2010 | 5 | SEC filing |
| Dec 8, 2010 | Initial | $2,025,000 | No comparison | 5 | SEC filing |
| Dec 21, 2009 | Amendment | $1,242,000 | No comparison | 6 | SEC filing |
| Mar 17, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 25, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-223906
Source: Form D, filed Apr 5, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Filip Amram | Director |
| Jason Bablak | Executive |
| Lalit Chordia | Director |
| Mazen Hanna | Executive |
| Raymond K. Houck | Director, Executive |
| Ira Kalfus | Executive |
| Brian Moyer | Executive |
| Houck Raymond | Director, Executive |
| Robert Roy | Director |
| Phillip Sussman | Director |
| Philip Sussman | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
150 Gamma Drive
Pittsburgh, PA, 15238
Pittsburgh, PA, 15238